• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度认知障碍型阿尔茨海默病筛查指南及临床标准的制定。DESCRIPA研究。

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.

作者信息

Visser P J, Verhey F R J, Boada M, Bullock R, De Deyn P P, Frisoni G B, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset P-J, Rigaud A-S, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund L-O, Wilcock G, Winblad B

机构信息

Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands.

出版信息

Neuroepidemiology. 2008;30(4):254-65. doi: 10.1159/000135644. Epub 2008 Jun 2.

DOI:10.1159/000135644
PMID:18515975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2821431/
Abstract

BACKGROUND

There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predementia phase, but validated diagnostic approaches are currently lacking. In this paper, we present the background, design and methods of a study, which aims to develop clinical criteria for predementia AD. We also present baseline characteristics of the subjects included. The study was part of the multicentre DESCRIPA project, which is being conducted within the network of the European Alzheimer's Disease Consortium.

METHODS

Clinical criteria will be based on a prospective cohort study of non-demented subjects older than 55 years and referred to a memory clinic. At baseline, a number of markers and risk factors for AD were collected, including demographic variables, measures of performance in activities of daily living, cognitive, neuroimaging and genetic markers, and serum and cerebrospinal fluid markers. Subjects will be reassessed annually for 2-3 years, and we will evaluate which combination of variables best predicts AD-type dementia at follow-up.

RESULTS

Between 2003 and 2005, 881 subjects were included from 20 memory clinics. Subjects were on average 70.3 years old, and had 10.4 years of education. The average score on the Mini-Mental State Examination was 27.4.

摘要

背景

迫切需要识别处于痴呆前期的阿尔茨海默病(AD)患者,但目前缺乏经过验证的诊断方法。在本文中,我们介绍一项研究的背景、设计和方法,该研究旨在制定痴呆前期AD的临床标准。我们还展示了所纳入受试者的基线特征。该研究是多中心DESCRIPA项目的一部分,该项目正在欧洲阿尔茨海默病联盟网络内开展。

方法

临床标准将基于一项对55岁以上非痴呆受试者进行的前瞻性队列研究,这些受试者被转诊至记忆门诊。在基线时,收集了一些AD的标志物和风险因素,包括人口统计学变量、日常生活活动能力指标、认知、神经影像学和基因标志物,以及血清和脑脊液标志物。受试者将在2至3年内每年进行重新评估,我们将评估哪些变量组合能在随访时最好地预测AD型痴呆。

结果

在2003年至2005年期间,从20个记忆门诊纳入了881名受试者。受试者平均年龄为70.3岁,受教育年限为10.4年。简易精神状态检查表的平均得分为27.4。

相似文献

1
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.轻度认知障碍型阿尔茨海默病筛查指南及临床标准的制定。DESCRIPA研究。
Neuroepidemiology. 2008;30(4):254-65. doi: 10.1159/000135644. Epub 2008 Jun 2.
2
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?药物试验中的轻度认知障碍标准能否准确识别出患有痴呆前阿尔茨海默病的受试者?
J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1348-54. doi: 10.1136/jnnp.2004.047720.
3
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).德国神经退行性疾病研究中心(DZNE)关于前驱期阿尔茨海默病的多中心观察性研究(DELCODE)的设计和初步基线数据。
Alzheimers Res Ther. 2018 Feb 7;10(1):15. doi: 10.1186/s13195-017-0314-2.
4
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.DESCRIPA研究中主观认知障碍或轻度认知障碍患者脑脊液阿尔茨海默病病理标志物的患病率及预后价值:一项前瞻性队列研究
Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10.
5
Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.经组织学确诊的阿尔茨海默病的准确预测及痴呆的鉴别诊断:NINCDS-ADRDA和DSM-III-R标准、单光子发射计算机断层扫描(SPECT)、X线计算机断层扫描(CT)以及载脂蛋白E4(Apo E4)在内侧颞叶痴呆中的应用。牛津记忆与衰老研究项目。
Int Psychogeriatr. 1998 Sep;10(3):271-302. doi: 10.1017/s1041610298005389.
6
Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.阿尔茨海默病连续体中的依赖程度作为临时临床里程碑:来自 GERAS 观察性研究的 18 个月结果。
J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.
7
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.脑脊液神经颗粒蛋白:与阿尔茨海默病认知及神经退行性变的关系
Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.
8
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.通过聚类分析识别的单域遗忘型轻度认知障碍可预测欧洲前瞻性 DESCRIPA 研究中的阿尔茨海默病。
Dement Geriatr Cogn Disord. 2013;36(1-2):1-19. doi: 10.1159/000348354. Epub 2013 May 3.
9
Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.使用 CERAD-NB 总分对阿尔茨海默病进行为期三年的随访:库奥皮奥 ALSOVA 研究。
Int Psychogeriatr. 2013 Aug;25(8):1335-44. doi: 10.1017/S1041610213000653. Epub 2013 May 16.
10
Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.功能独立性测量在阿尔茨海默病和血管性痴呆患者评估中的临床应用。
Psychogeriatrics. 2013 Dec;13(4):199-205. doi: 10.1111/psyg.12012. Epub 2013 Oct 28.

引用本文的文献

1
Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries.不同血统人群中载脂蛋白E与阿尔茨海默病病理学的性别差异
JAMA Netw Open. 2025 Mar 3;8(3):e250562. doi: 10.1001/jamanetworkopen.2025.0562.
2
Storage time affects the level and diagnostic efficacy of plasma biomarkers for neurodegenerative diseases.储存时间会影响神经退行性疾病血浆生物标志物的水平及诊断效能。
Neural Regen Res. 2025 Aug 1;20(8):2373-2381. doi: 10.4103/NRR.NRR-D-23-01983. Epub 2024 Apr 16.
3
European Projects for Patients with Dementia and Their Caregivers.面向痴呆症患者及其护理人员的欧洲项目。
Adv Exp Med Biol. 2023;1425:609-618. doi: 10.1007/978-3-031-31986-0_59.
4
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease.血浆淀粉样蛋白β42/40和载脂蛋白E用于阿尔茨海默病二级预防试验中的淀粉样蛋白PET预筛查。
Brain Commun. 2023 Jan 24;5(2):fcad015. doi: 10.1093/braincomms/fcad015. eCollection 2023.
5
Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation.神经元内质网信号体蛋白作为前驱性阿尔茨海默病的早期生物标志物,独立于淀粉样β蛋白生成和 Tau 蛋白磷酸化
Front Mol Neurosci. 2022 May 5;15:879146. doi: 10.3389/fnmol.2022.879146. eCollection 2022.
6
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.在用于阿尔茨海默病(AD)多模态生物标志物发现队列的欧洲医学信息框架中,性别特异性代谢途径与AD内表型相关。
Biomedicines. 2021 Nov 3;9(11):1610. doi: 10.3390/biomedicines9111610.
7
Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts.医学信息学平台(MIP):一项针对意大利临床队列的试点研究。
Front Neurol. 2020 Sep 23;11:1021. doi: 10.3389/fneur.2020.01021. eCollection 2020.
8
Predictors of Dementia in the Oldest Old: A Novel Machine Learning Approach.高龄老人痴呆症的预测因素:一种新颖的机器学习方法。
Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):325-332. doi: 10.1097/WAD.0000000000000400.
9
Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.利用机器学习将阿尔茨海默病的结构 MRI 神经退行性变模式量化为痴呆评分:在 ADNI、AIBL、OASIS 和 MIRIAD 数据库的 8834 张图像上进行独立验证。
Hum Brain Mapp. 2020 Oct 1;41(14):4127-4147. doi: 10.1002/hbm.25115. Epub 2020 Jul 2.
10
Predicting conversion to Alzheimer's disease among individual high-risk patients using the Characterizing AD Risk Events index model.使用 Characterizing AD Risk Events 指数模型预测个体高危患者向阿尔茨海默病的转化。
CNS Neurosci Ther. 2020 Jul;26(7):720-729. doi: 10.1111/cns.13371. Epub 2020 Apr 3.

本文引用的文献

1
Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?阿尔茨海默病协会轻度认知障碍研究圆桌会议:我们学到了什么?
Alzheimers Dement. 2006 Jul;2(3):220-33. doi: 10.1016/j.jalz.2006.04.010.
2
Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.轻度认知障碍全谱系中阿尔茨海默病痴呆的临床预测
Arch Gen Psychiatry. 2007 Dec;64(12):1443-50. doi: 10.1001/archpsyc.64.12.1443.
3
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.阿尔茨海默病诊断的研究标准:修订NINCDS-ADRDA标准
Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3.
4
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.卡巴拉汀对从轻度认知障碍发展到阿尔茨海默病的诊断延迟的影响:InDDEx研究
Lancet Neurol. 2007 Jun;6(6):501-12. doi: 10.1016/S1474-4422(07)70109-6.
5
Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.临床前痴呆:一项关于遗忘型轻度认知障碍的意大利多中心研究。
Dement Geriatr Cogn Disord. 2007;23(5):289-300. doi: 10.1159/000100871. Epub 2007 Mar 13.
6
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.轻度认知障碍中的海马体和内嗅皮质萎缩:阿尔茨海默病的预测
Neurology. 2007 Mar 13;68(11):828-36. doi: 10.1212/01.wnl.0000256697.20968.d7.
7
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.遗忘型轻度认知障碍进展为阿尔茨海默病的临床预测因素。
Neurology. 2007 May 8;68(19):1588-95. doi: 10.1212/01.wnl.0000258542.58725.4c. Epub 2007 Feb 7.
8
Ten-year risk of dementia in subjects with mild cognitive impairment.轻度认知障碍患者患痴呆症的十年风险。
Neurology. 2006 Oct 10;67(7):1201-7. doi: 10.1212/01.wnl.0000238517.59286.c5.
9
Reliability, validity and factor structure of the GDS-15 in Iranian elderly.伊朗老年人中GDS-15量表的信度、效度及因子结构
Int J Geriatr Psychiatry. 2006 Jun;21(6):588-93. doi: 10.1002/gps.1533.
10
Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study.轻度认知障碍患者认知缺陷的演变及向痴呆的转化:一项长期随访研究。
Dement Geriatr Cogn Disord. 2006;21(5-6):380-91. doi: 10.1159/000092534. Epub 2006 Apr 4.